Literature DB >> 633073

Urinary anthracycline metabolites from mice treated with adriamycin and N-trifluoroacetyladriamycin-14-valerate.

M Israel, W J Pegg, P M Wilkinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 633073

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  5 in total

1.  Comparative effects of adriamycin and DNA-non-binding analogues on DNA, RNA, and protein synthesis in vitro.

Authors:  M Israel; J M Idriss; Y Koseki; V K Khetarpal
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Distribution of radioactivity and anthracycline-fluorescence in tissues of mice one hour after [14C]-labeled AD 32 administration. Evidence for tissue aglycone formation.

Authors:  M Israel; A M Karkowsky; V K Khetarpal
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

3.  Comparative metabolism and excretion of adriamycin in man, monkey, and rat.

Authors:  P M Wilkinson; M Israel; W J Pegg; E Frei
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

4.  Radioactive species in rat urines and tissues after [14C] AD 32 administration.

Authors:  G Zini; G P Vicario; M Lazzati; F Arcamone
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

5.  Pharmacologic studies with radiolabeled N-trifluoroacetyladriamycin-14-valerate (AD 32). Comparison of total anthracycline fluorescence and radioactivity in mouse serum and urine.

Authors:  M Israel; A M Karkowsky; W J Pegg
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.